Member Info for Mambamentality

Forulamb also applying to Alzeimers. Basically the holly grail.

https://www.bloomberg.com/news/videos/2021-07-01/tiziana-life-sciences-chairman-on-alzheimer-and-covid-efforts-video

Dr Weiner explained in the last interview with Bloomberg, that Tiziana is not working specifically at the type of strain bur what happens in the body when the strain is there so Foralumab could work on any strain of Coronavirus. The treatment can also be given at home as it would be the nasal spray.

https://www.bloomberg.com/news/videos/2021-07-01/tiziana-life-sciences-chairman-on-alzheimer-and-covid-efforts-video

According to CEO the stock is one of the most traded in Aquis. The problem is that it is mostly sells. Good progress but it seems not enough to call the attention of new investors. The LSE listing seems to be in early stages. I am out.

https://www.youtube.com/watch?v=k0mu8HIZ8Pg

I think the increase in US was due to a double bottom formation and the view that the share price should be much higher.

Another top up for me.
One of the top analyst in the Biotech space, Wainwright & Co, wrote back in January 2021 "Thus, if the Brazilian
trial proves successful, this could constitute meaningful upside to our
estimates. Foralumab is also advancing in two Phase 2 programs, one
in Crohn's Disease and the other in progressive multiple sclerosis (MS).
We reiterate our Buy rating and 12-month price target of $11 per share".

With Howard Weiner, Professor Napoleone Ferrara, Kevan Herold and Arun Sanyal in the advisory board, I am confident in the future of the company.

Need to agree with the CEO that "8m @ 19.11 g/t Au and 32m @ 4.43 g/t Au in oxides are really impressive drill results". Looking very promising.

StarKnight. According to Sir Patrick Vallance 40% of coronavirus-related hospital admissions were double-jabbed people and 60% were not. Not many countries will have the capacity to double jabbed everyone. If something is certain at this point is that Covid is here to stay. A treatment along vaccines is required may be for the rest of our days. Hopefully we see renew interest in stocks looking for a treatment to covid. Even though we know TILS is much more than that. Let's also see if Cerrone decides to purchase some share as he has done in the past when the share price went down. His last purchase was at 71p.

It is oversold. A bullish reversal is on the cards. I topped up. The fundamentals are even better at this point than when the share price was 268p. It would be perfect timing to receive an update in the covid front given the current weakness in the markets because of the Delta variant.

It seems that for the first time since 11 May 2020, it is entering oversold. Anyone knows when we are likely to receive confirmation of a Move to Official List - the intention to move was made on 8 April 2021. Also, it seems we should receive interim results for the six months ended 30 June 2021, in the near future. Any of the above should do the trick to have a fast reversal.

Got 5k. The trust fund has been selling for at least 3 months and I guess they took the opportunity during the raise to 28p to sell a good amount. Brad said during the webinar that under Canadian rules any amount below 10% is not disclosable thus OMI will only be informed when the trust are done selling at which point OMI should report that to the market. Then an RNS should follow in September saying that the Loryser creditors have been paid. We should see a nice spike the day we receive the RNS saying that they are done selling and that the creditors have been paid.

Nookie. You are getting really wrong comparing GGP to Alba minerals. There is no point of comparison. You cannot confuse sampling to actual drilling results.

If you wish to compare it to something in relation to chip sampling look at the RNS from Serabi Gold today:
"Surface sampling totalling 69 rock chip samples with an average grade of 8.33g/t Au over an area of 1.5km x 1.5km and a maximum result of 204.77g/t Au, reflects the prospectivity of the area".

I am pleased to see Shaun Day active on Twitter, visiting Havieron and providing interviews. Looking forward to receiving another wold class intersections reported. I topped up again today in anticipation of the results. Now my largest holding as in the old times. It would be perfect to close today above the 50 day Moving average at 19.72p. A good RNS could take us to the last resistance at 23.70p. RSI at 52 which is positive too.

I had not noticed but this is actually pretty oversold in the day chart so I bought back. Even John Cornford - from Master investors who had been a bit bearish on the prospects here has changed his view. If we see 40p before the end of the year it would not be a bad return for 5 months investment.

From the 15th July issue: "And as for Solgold (LON:SOLG), (copper mostly but a lot of gold too) having been cautious for a long time now I see little reason any more for its shares to stay stuck down where they are below 30p, which is why if I had the funds I would be piling in again. As I have surmised before, however, despite the much better news starting to come along, it seems likely that potential institutional buyers of the shares think they are all sewn up between Solgold’s major shareholders, giving little chance that any bid would succeed, so they would have to wait too long to see Solgold’s value fully unlocked. But when that news (a revised and much more economic feasibility study for Alpala and a possibly much earlier start) comes along in October, together with continuing success at its other Ecuadorian exploration prospects and, possibly, partnerships to help their funding burden, private investors at least won’t want to pass the opportunity by. So, the shares have a good chance by the end of the year of seeing at least 40p again in my view".

I am encouraged by the movement in stocks which have been oversold recently such as EQT, OMI, ARB and XTR. They are having a good recovery. I guess with the current market the best is to buy oversold stocks.

Entering oversold. A reversal should be on the cards. Did not think we would see these prices with important updates in the near future. A good opportunity to buy/top up at these prices.

I meant ANZA. APTA for the moment looks pretty good and should be enough for the JV partners to make the next payment to continue drilling in the projects which seem to be even more promising than APTA such as Guaimarala and La Cejita later in the year.

I bought another 5K. APTA on itself is a company maker. Bringing Agnico has derisked to some extent the project in the sense that they could take the project in a smaller scale than Newmont and have greater expertise of dealing with Polimetalic deposits which seems to be the emerging picture of APTA. However, the project is not completely derisked. But, there are not many projects which are completely derisked in the junior market.

Closing above 21.54p could take the share price to 25p.

Looking at the slides it looks like Brad is very keen to get the JV done.

"Subsequent to establishing its position in Ariquemes, Meridian began to deliver exciting drill results from its Cabaçal Copper/Gold project in the neighbouring state of Mato Grosso, such that this has now become its primary asset, limiting its ability to allocate the resources that are required to Ariquemes".

Brad should be getting us the Cabaçal Copper/Gold JV not the tin. Meridian goes from Tin to Gold/copper. OMI from gold to Tin.

Bought at 1.10. Unless someone knows something we do not know seems like a good opportunity to top up.

The placing has been expected and that is what has put some investors off. I do not think they would have any problem raising funds at a big discount as much juniors do.

The small amount is because:
"The program, which has already commenced at the project in Uganda and is fully funded through the Company’s existing cash resources, is designed to in-fill the recently announced JORC Resource and upgrade substantial tonnes into the Indicated and Measured categories.?".